Acquisition to include Red One™ solid-phase cytometry platform for rapid sterility and bioburden testing, which expands Lonza’s portfolio of automated, scalable solutions for pharmaceutical quality control
Advancing clinical pharmacokinetic prediction beyond non-human primate models
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing
Discover how advanced imaging technology is enabling continuous drug safety monitoring in liver organoids
Activace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epigenome that can be scaled to the study of large patient cohorts
Agreement will expand the availability of Gencurix’s in vitro diagnostic (IVD) assays using Droplet Digital™ PCR (ddPCR™) for clinical testing of critical oncology biomarkers across Europe
Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date
Researchers say the work demonstrates that precise gene editing can prevent infection by disrupting a pig protein the virus relies on to make copies of itself within the cells of the pig
New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research
AI tool connects researchers to verified medical and life sciences global databases, enabling accurate extraction and summarisation of academic papers, journals, and articles
Combines single-organ, multi-organ, and higher-throughput configurations within one scalable platform
One test to diagnose all: In this guest editorial, Neil Ward, VP of PacBio EMEA, explores why current diagnostic pathways for rare diseases are falling short
FDA clearance of MBT FAST™ Shuttle US IVD and MBT Compass HT CA software improves workflow efficiency and accelerates data processing and FDA approval of expanded reference library increases coverage to 549 validated microbial species
New facility expands the company’s capacity to meet the growing demand for comprehensive cell analysis solutions
In this guest editorial, Dr. Katherine Bridge, University of York, explains how aptamers could unlock new opportunities for more targeted and effective cancer treatments
In this guest editorial, Jeremy Lambert shares how Stellaromics delivers true, high-resolution 3D spatial transcriptomics
The newly-added solutions provide researchers and manufacturers with high-performance, scalable, and regulatory-ready solutions that streamline cell and gene therapy workflows from discovery through clinical development
In this guest editorial, Kelly Hines and Daniel DeBord discuss how IM-MS streamlines multiomics by capturing proteomic, lipidomic, and metabolomic information in a single, rapid analysis
Optimized, automated protocols on SPT Labtech’s firefly®+ using Agilent’s SureSelect Max DNA Library Prep Kit supports high-throughput sequencing in clinical research, oncology, and precision medicine
Partnership to enable automated workflows for 10x Genomics’ Chromium Single Cell Platform on SPT Labtech’s firefly liquid handling platform
The knowledge could reduce the risk of severe bowel complications from radiotherapy, heralding a more personalized approach to prostate cancer treatment
From sample limitations to isomeric separations, see how the right column choice transformed a challenging lipidomics project
Combined portfolio unites Fluidic Sciences’ in‑solution microfluidic diffusional sizing technology with Sphere Bio’s proprietary picodroplet-microfluidic platforms, Cyto‑Mine Chroma, and high‑throughput assays – delivering end‑to‑end insight from cells to molecules
